Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
04/01/1998 | EP0831836A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
04/01/1998 | EP0831830A1 Imidazole compounds |
04/01/1998 | EP0831827A1 Novel formulations for transdermal delivery of pergolide |
04/01/1998 | EP0831812A2 Methods and compositions for stimulating neurite growth |
04/01/1998 | EP0831810A1 Transdermal formulation comprising ropinirole |
04/01/1998 | EP0831800A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS |
04/01/1998 | EP0831799A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders |
04/01/1998 | EP0741707B1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
04/01/1998 | EP0625987B1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
04/01/1998 | EP0453515B1 Composition for treatment of senile dementia |
04/01/1998 | CN1177498A Chinese traditional medicine for treating epilepsy |
04/01/1998 | CN1177495A Xueguiling analgesic |
03/31/1998 | US5734059 Production intermediate and process for producing pyridine derivative |
03/31/1998 | US5734051 8-substituted xanthine derivatives and method of use thereof |
03/31/1998 | US5734038 Purified polynucleotide sequence which codes for a diazepam binding inhibitor protein(or polypeptide) or an acyl-coenzyme a binding protein(or polypeptide) |
03/31/1998 | US5733936 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients |
03/31/1998 | US5733930 Topical gel; anaesthesia |
03/31/1998 | US5733926 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
03/31/1998 | US5733912 Nervous system disorders in nerve cells |
03/31/1998 | US5733910 Pyridazinedione compounds useful in the treating neurological disorders |
03/31/1998 | US5733908 Useful in the treatment of parkinson's disease and schizophrenia |
03/31/1998 | US5733881 Analgesics, immunosuppressants |
03/31/1998 | US5733875 Epilepsy |
03/31/1998 | US5733867 Cholecystokinins and gastrin antagonist |
03/31/1998 | US5732717 Administering 4-chloro-5-(imidazoline-2-ylamino)-6-methoxy-2-methylpyrimidine |
03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
03/31/1998 | CA2116356C Antimuscarinic bronchodilators |
03/31/1998 | CA1339791C Human nerve growth factor |
03/27/1998 | CA2216479A1 Pharmaceutical formulations and methods for treating patients suffering from diseases that cause muscular hypotonia |
03/26/1998 | WO1998012211A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
03/26/1998 | WO1998012210A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
03/26/1998 | WO1998012190A2 Phenoxathiin derivatives as inhibitors of monoamine oxidase |
03/26/1998 | WO1998012177A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists |
03/26/1998 | WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons |
03/26/1998 | WO1998011915A1 Strain selection of pneumococcal surface proteins |
03/26/1998 | WO1998011897A1 Combination therapy for treatment of psychoses |
03/26/1998 | WO1998011893A1 Olanzapine dihydrate d |
03/26/1998 | WO1998011890A1 Use of benzopyranols to treat neurological disorders |
03/26/1998 | WO1998011882A1 Pharmaceutical compositions and methods |
03/26/1998 | WO1998011881A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications |
03/26/1998 | WO1997048724A3 Human metabotropic glutamate receptor |
03/26/1998 | WO1997043272A3 Benzofurans and benzopyrans as chronobiological agents |
03/26/1998 | DE19704301C1 Human endoglin gene promoter |
03/26/1998 | CA2267343A1 Strain selection of pneumococcal surface proteins |
03/26/1998 | CA2266849A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
03/26/1998 | CA2266681A1 Use of benzopyranols to treat neurological disorders |
03/26/1998 | CA2266496A1 Pharmaceutical compositions and methods |
03/26/1998 | CA2265943A1 Phenoxathiin derivatives as inhibitors of monoamine oxidase |
03/26/1998 | CA2265896A1 Identification of agents that protect against inflammatory injury to neurons |
03/26/1998 | CA2265894A1 Pharmaceutical compositions containing amisulpride and their therapeutic applications |
03/25/1998 | EP0831097A2 Olanzapine dihydrate D |
03/25/1998 | EP0830864A1 Combination therapy for treatment of psychoses |
03/25/1998 | EP0830861A1 Use of PKC inhibitors for the manufacture of a medicament for the treatment of HTLV-1 infections |
03/25/1998 | EP0830858A1 Formulation comprising coated olanzapine particles |
03/25/1998 | EP0830372A1 Cyclic prodrugs of peptides and peptide nucleic acids having improved metabolic stability and cell membrane permeability |
03/25/1998 | EP0830369A1 Novel nor-pregnanes for inducing hypothalamic effects |
03/25/1998 | EP0830348A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
03/25/1998 | EP0830347A1 Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
03/25/1998 | EP0830136A1 New cryptophycins from synthesis |
03/25/1998 | EP0801646A4 Pharmaceutical compositions for prevention and treatment of central nervous system disorders |
03/25/1998 | CN1177381A Process for producing phosphatidylserines having polybasic unsaturated fatty acid and as side chain |
03/25/1998 | CN1177351A Hydroxylamine derivatives useful for enhancing molecular chaperon prodn. and the prepn. thereof |
03/25/1998 | CN1177349A Certain 4 -aminomethyl -2 -substituted imidazole derivatives and 2 -aminomethyl -4 -substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands |
03/25/1998 | CN1177299A Certain 1, 4, 5 -tri- substituted imidazole compounds useful as cytokine |
03/25/1998 | CN1037841C Process for preparing substituted 4 -phenyl -4 - piperidinecarboxamide having local anaesthetis and analgestic effect |
03/24/1998 | US5731432 Inhibitors of adenosine monophosphate deaminase |
03/24/1998 | US5731352 Therapy for disorders of the melatoninergic system |
03/24/1998 | US5731349 Glycine |
03/24/1998 | US5731348 Alkylcarboxy amino acids-modulators of the kainate receptor |
03/24/1998 | US5731340 Dietetics; antidiabetic agents |
03/24/1998 | US5731337 Conformationally rigid bicycle and adamantane derivatives useful as α2 |
03/24/1998 | US5731336 Method for treating multiple sclerosis |
03/24/1998 | US5731335 Nervous system disorders; stroke; antiischemic agents; cognition activators |
03/24/1998 | US5731333 Learning and memory enhancement, antidepressants |
03/24/1998 | US5731332 Leukotriene antagonists; antiinflammatory agents, antiallergens |
03/24/1998 | US5731331 Tetrahydropyridine-(or 4-hydroxypiperidine) alkylazoles |
03/24/1998 | US5731322 Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives |
03/24/1998 | US5731319 Antiallergens; antihistamines |
03/24/1998 | US5731313 Use of anthracyclinone derivatives in amyloidosis |
03/24/1998 | US5731306 Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo c!azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
03/24/1998 | US5731286 Cyclic neurokinin A antagonists |
03/24/1998 | US5731284 Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product |
03/24/1998 | US5731000 Stabilized pharmaceutical composition containing bupropion |
03/24/1998 | US5730998 Administering substance p antagonist |
03/24/1998 | US5730985 Methyl ecgonine phenylphosphonate as chemical intermediate of cocaine |
03/24/1998 | CA2129037C Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
03/20/1998 | CA2185950A1 Process for preparing intermediates for thrombin inhibitors |
03/19/1998 | WO1998011243A2 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian dna virus having an altered coat protein |
03/19/1998 | WO1998011213A1 Method for treating amyotrophic lateral sclerosis |
03/19/1998 | WO1998011212A1 Ptx sensitive g proteins, the production and use thereof |
03/19/1998 | WO1998011135A1 A taxol-like protein (talp) and process for preparing the same |
03/19/1998 | WO1998011129A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
03/19/1998 | WO1998011128A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
03/19/1998 | WO1998011119A1 Novel pyranoside derivatives |
03/19/1998 | WO1998011110A1 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use |
03/19/1998 | WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes |
03/19/1998 | WO1998011090A2 3-alkyl-3-phenyl-piperidines |
03/19/1998 | WO1998011086A1 Chromone derivatives and nerve cell death inhibitors containing the same |
03/19/1998 | WO1998011075A1 Pyrazinones and triazinones and their derivatives thereof |
03/19/1998 | WO1998011068A1 D4 receptor selectivity piperazine derivatives |